✦ LIBER ✦

Anti-TNF antibody therapy in Crohn's disease: the risk of a switch

✍ Scribed by Ricart, E.; Ordas, I.; Panes, J.

Book ID: 119951877
Publisher: BMJ Publishing Group
Year: 2011
Tongue: English
Weight: 62 KB
Volume: 61
Category: Article
ISSN: 0017-5749
DOI: 10.1136/gutjnl-2011-301478

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mo1197 Dermatological Complications of A

Mo1197 Dermatological Complications of Anti-TNF-a Therapy in Crohn's Disease

✍ Nardelli, Andrea; Chauhan, Usha K.; Marshall, John K.; Halder, Smita L.; Tse, Fr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Untoward effect of anti-TNF therapy in C

Untoward effect of anti-TNF therapy in Crohn's disease — A case report

✍ Annese, V.; Lombardi, G.; Napolitano, G.; Caruso, N.; Conoscitore, P.; Andriulli 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 172 KB

The efficacy and safety of a third anti-

The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn’s disease after failure of two other anti-TNF antibodies

✍ M. ALLEZ; S. VERMEIRE; N. MOZZICONACCI; P. MICHETTI; D. LAHARIE; E. LOUIS; M.-A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Anti-TNF-α antibodies improve intestinal

Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease

✍ Rainer Noth; Eckhard Stüber; Robert Häsler; Susanna Nikolaus; Tanja Kühbacher; J 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 382 KB

Effect of anti-TNF therapy on lymphocyte

Effect of anti-TNF therapy on lymphocyte proliferation in Crohn's disease

✍ A.G. Bonanomi; S. Bagnoli; G. d'Albasio; M. Milla; M. Stio; M. Martinesi; C. Tre 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Practical application of anti-TNF therap

Practical application of anti-TNF therapy for luminal Crohn's disease

✍ Michael A. Kamm; Siew C. Ng; Peter De Cruz; Patrick Allen; Stephen B. Hanauer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 913 KB

Anti-tumor necrosis factor (TNF) therapy to treat inflammatory bowel disease has been available for more than a decade. Although extensive data on the outcome of anti-TNF therapy from individual clinical trials and patient cohorts are available, integrated guidance on the best use of such therapy to